Sun Pharma Announces Settlement Of Patent Litigation For Generic Revlimida

Sun Pharma Announces Settlement Of Patent Litigation For Generic Revlimida

By, Admin 23 June 2021

India, June 22, 2021 - Sun Pharmaceutical Industries Limited, &Ldquo;Sun Pharma&Rdquo; And Includes Its Subsidiaries And/Or Associate Companies) Along With One Of Its Wholly Owned Subsidiaries Today Announced That They Have Reached An Agreement With Celgene Corporation (Celgene), A Wholly-Owned Subsidiary Of Bristol Myers Squibb, To Resolve The Patent Litigation Regarding Submission Of An Abbreviated New Drug Application (Anda) For A Generic Version Of Revlimid&Reg; (Lenalidomide Capsules) In The Us.Pursuant To The Terms Of The Settlement, Celgene Will Grant Sun Pharma A License To Celgene&Rsquo;S Patents Required To Manufacture And Sell (Subject To Usfda Approval) Certain Limited Quantity Of Generic Lenalidomide Capsules In The Us Beginning On A Confidential Date That Is Sometime After March 2022. In Addition, The License Will Also Allow Sun Pharma To Manufacture And Sell An Unlimited Quantity Of Generic Lenalidomide Capsules In The Us Beginning January 31, 2026.As A Result Of The Settlement, All Hatch-Waxman Litigation Between Sun Pharma And Celgene, Regarding The Revlimid&Reg; Patents, Will Be Dismissed. Additional Details Regarding The Settlement Are Confidential. The Agreement Is Subject To Customary Regulatory Approvals.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!